Search for: "Amgen Inc. v. Sandoz Inc."
Results 41 - 60
of 88
Sorted by Relevance
|
Sort by Date
15 May 2019, 12:54 am
There is also a look at the Federal Circuit’s decision in Amgen Inc. v. [read post]
29 Sep 2020, 10:23 am
Immunex and Roche v. [read post]
15 Feb 2021, 9:52 am
by Dennis crouch Sandoz Inc. v. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
12 Aug 2022, 6:48 pm
(quoting Amgen Inc. v. [read post]
4 Mar 2016, 12:25 pm
New petitions include Sandoz v. [read post]
11 Apr 2016, 2:38 am
| Napp v Dr Reddy's and Sandoz. [read post]
16 Jan 2017, 5:44 pm
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
18 Sep 2016, 6:03 pm
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation: Grunenthal GmbH v. [read post]
13 Oct 2016, 6:50 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Eligibility: Trading Technologies International, Inc. v. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Mylan Pharmaceuticals, et al. v. [read post]
14 Nov 2016, 9:16 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Licensing: DataTreasury Corp. v. [read post]
5 Sep 2016, 6:46 pm
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
18 Apr 2016, 9:58 am
Sandoz, Inc., 135 S. [read post]
8 Feb 2017, 3:09 am
Briefing: Sandoz Inc. v. [read post]
3 Jun 2016, 6:40 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
1 Apr 2016, 8:22 am
First Quality Baby Products, LLC, et al., No. 15-927 (three amici filed in support) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
8 May 2009, 8:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) – US: Federal Circuit revises Amgen v ITC (Patently-O) (Patent Baristas) (ITC 337 Law Blog) (Hal Wegner) (Patent Docs) General Alicia Greenidge to step down as Director of IFPMA (Intellectual Property Watch) Flu crisis could lead to compulsory licences… [read post]
28 Jun 2016, 6:41 am
(post-sale restrictions); and Sandoz v. [read post]
